Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-11 Sale | 2022-04-13 5:49 pm | Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer | 2,741 | $0.9 | $2,467 | 94,563 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-12 Disposition | 2022-08-16 7:03 pm | N/A N/A | Epizyme Inc. | EPZM | Giordano Michael F Director | 17,054 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 7:02 pm | N/A N/A | Epizyme Inc. | EPZM | GOLDFISCHER CARL Director | 3,403,005 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 7:02 pm | N/A N/A | Epizyme Inc. | EPZM | Conroy Kevin T Director | 62,318 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:59 pm | N/A N/A | Epizyme Inc. | EPZM | Richon Victoria Director | 22,608 | $0 | 0 (Direct) | View |
| 2022-08-12 Equity Swap | 2022-08-16 6:59 pm | N/A N/A | Epizyme Inc. | EPZM | MOTT DAVID M Director | 322,453 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:59 pm | N/A N/A | Epizyme Inc. | EPZM | MOTT DAVID M Director | 8,994 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:58 pm | N/A N/A | Epizyme Inc. | EPZM | BEVERIDGE ROY A Director | 46,037 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:57 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 286,539 | $0 | 0 (Direct) | View |
| 2022-08-12 Equity Swap | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 31,933,334 | $0 | 0 (Indirect) | View |
| 2022-08-12 Disposition | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 17,054 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks | 52,076 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | BATE KENNETH Director | 17,054 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:54 pm | N/A N/A | Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer | 120,067 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:54 pm | N/A N/A | Epizyme Inc. | EPZM | Stuckley Carol Director | 25,696 | $0 | 0 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:52 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. President and CEO | 259,170 | $0 | 0 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 417,500 | $1.41 | 259,170 (Direct) | View |
| 2022-08-09 Tax Withholding | 2022-08-11 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 395,083 | $1.41 | 259,170 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 800,000 | $1.39 | 259,170 (Direct) | View |
| 2022-08-09 Tax Withholding | 2022-08-11 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 746,307 | $1.39 | 259,170 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 9:00 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 1,217,500 | $0 | 259,170 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 8:53 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 500,000 | $1.39 | 1,129,035 (Direct) | View |
| 2022-08-09 Tax Withholding | 2022-08-11 8:53 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 373,154 | $1.39 | 1,129,035 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 8:53 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 500,000 | $0 | 1,129,035 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 8:53 pm | N/A N/A | Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks | 300,000 | $1.39 | 51,099 (Direct) | View |
| 2022-08-09 Tax Withholding | 2022-08-11 8:53 pm | N/A N/A | Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks | 279,864 | $1.39 | 51,099 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 8:53 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks | 300,000 | $0 | 51,099 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 8:52 pm | N/A N/A | Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer | 380,000 | $1.39 | 120,067 (Direct) | View |
| 2022-08-09 Tax Withholding | 2022-08-11 8:52 pm | N/A N/A | Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer | 354,496 | $1.39 | 120,067 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 8:52 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer | 380,000 | $0 | 120,067 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:06 pm | N/A N/A | Epizyme Inc. | EPZM | MOTT DAVID M Director | 16,156 | $1.47 | 331,447 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:06 pm | N/A N/A | Epizyme Inc. | EPZM | BEVERIDGE ROY A Director | 8,928 | $1.47 | 46,037 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:02 pm | N/A N/A | Epizyme Inc. | EPZM | Conroy Kevin T Director | 10,204 | $1.47 | 62,318 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 6:01 pm | 2023-05-17 2032-05-16 | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 41,006 | $0.56 | 31,980,464 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 6:01 pm | 2023-05-17 N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 8,994 | $0 | 31,980,464 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:30 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | BATE KENNETH Director | 50,000 | $0 | 58,060 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:29 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | Richon Victoria Director | 50,000 | $0 | 63,614 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:29 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | Stuckley Carol Director | 50,000 | $0 | 66,702 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:28 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | Giordano Michael F Director | 50,000 | $0 | 58,060 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:26 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | MOTT DAVID M Director | 50,000 | $0 | 356,297 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:26 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | Conroy Kevin T Director | 50,000 | $0 | 93,120 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:23 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | GOLDFISCHER CARL Director | 50,000 | $0 | 3,444,011 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:20 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | BEVERIDGE ROY A Director | 50,000 | $0 | 78,115 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-04 6:48 pm | N/A 2032-03-31 | Epizyme Inc. | EPZM | Korn Jerald Chief Operating Officer | 800,000 | $0 | 800,000 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-01 5:31 pm | N/A N/A | Epizyme Inc. | EPZM | BEVERIDGE ROY A Director | 11,413 | $1.15 | 28,115 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-01 5:30 pm | N/A N/A | Epizyme Inc. | EPZM | MOTT DAVID M Director | 20,653 | $1.15 | 306,297 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-01 5:30 pm | N/A N/A | Epizyme Inc. | EPZM | Conroy Kevin T Director | 13,043 | $1.15 | 43,120 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-21 6:06 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 800,000 | $0 | 800,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-21 6:06 pm | N/A N/A | Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks | 2,331 | $1.2665 | 330,963 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-21 6:06 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks | 300,000 | $0 | 330,963 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-21 6:05 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer | 380,000 | $0 | 380,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-21 6:05 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 2,331 | $1.2665 | 658,716 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-21 6:05 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 500,000 | $0 | 658,716 (Direct) | View |